Combining venetoclax and azacytidine with T-cell bispecific antibodies for treatment of acute myeloid leukemia: a preclinical assessment.
Gerulf HänelAnne SchönleAnne-Sophie NeumannDaniel NixdorfNora PhilippMonika SponheimerAlexandra LeutbecherAlica-Joana EmhardtGiulia MagnoVeit L BückleinJan EckmannDiana DunsheeVesna KramarKoorosh KorfiSara ColombettiPablo UmañaChristiane NeumannMarion SubklewePublished in: Leukemia (2024)